Recombinetics Awarded NIH Grant to Develop a Humanized Swine Model of Alzheimer’s Disease
ST. PAUL, MINNESOTA – Recombinetics, a global biotechnology leader in gene editing of livestock for human therapeutics and food production applications, has been awarded a $358,338 Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Aging, National Institutes of Health (NIH) to create a genetically accurate [...]
Recombinetics Introduces New Executive Suite and Board of Directors
ST. PAUL, MN. – Recombinetics (recombinetics.com), a St. Paul-based gene-editing company, has hired Ian R. Friendly as Chief Executive Officer and Tammy Lee Stanoch as Chief Corporate Affairs Officer. The company’s previous CEO and founder, Dr. Scott Fahrenkrug, has been elevated to Executive Chairman of the Board and will also [...]